Central Trust CO Eli Lilly & CO Transaction History

Central Trust CO

$3.97 Billion
Q1 2025

A detailed history of Central Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Central Trust CO holds 43,761 shares of LLY stock, worth $34.8 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

43,761

Previous 45,080 2.93%

Holding current value

$34.8 Million

Previous $34.8 Million 3.85%

% of portfolio

0.91%

Previous 0.87%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$725.72 - $929.72 $957,224 - $1.23 Million	-1,319 Reduced 2.93%	43,761 $36.1 Million
Q4 2024 Jan 24, 2025	SELL	$727.2 - $932.06 $162,892 - $208,781	-224 Reduced 0.49%	45,080 $34.8 Million
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $662,496 - $823,697	858 Added 1.93%	45,304 $40.1 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $851,722 - $1.07 Million	-1,175 Reduced 2.58%	44,446 $40.2 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $348,805 - $466,652	-589 Reduced 1.27%	45,621 $35.5 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $505,232 - $595,603	-962 Reduced 2.04%	46,210 $26.9 Million
Q3 2023 Oct 26, 2023	BUY	$434.7 - $599.3 $183,443 - $252,904	422 Added 0.9%	47,172 $25.3 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $16,134 - $21,573	46 Added 0.1%	46,750 $21.9 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $359,709 - $422,461	-1,158 Reduced 2.42%	46,704 $16 Million
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $1.63 Million - $1.9 Million	5,062 Added 11.83%	47,862 $0
Q3 2022 Nov 17, 2022	BUY	$296.48 - $337.87 $469,031 - $534,510	1,582 Added 3.84%	42,800 $13.8 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $74,978 - $88,035	-269 Reduced 0.65%	41,218 $13.4 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $45,764 - $56,873	-195 Reduced 0.47%	41,487 $11.9 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $2,023 - $2,511	-9 Reduced 0.02%	41,682 $11.5 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $6,869 - $8,454	31 Added 0.07%	41,691 $9.63 Million
Q2 2021 Jul 23, 2021	SELL	$180.55 - $233.54 $45,318 - $58,618	-251 Reduced 0.6%	41,660 $9.56 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $182,395 - $236,119	-1,110 Reduced 2.58%	41,911 $7.83 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $10,697 - $14,155	82 Added 0.19%	43,021 $7.26 Million
Q3 2020 Oct 22, 2020	BUY	$146.22 - $169.13 $518,788 - $600,073	3,548 Added 9.01%	42,939 $6.36 Million
Q2 2020 Jul 14, 2020	SELL	$136.42 - $164.18 $175,845 - $211,628	-1,289 Reduced 3.17%	39,391 $6.47 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $116,073 - $143,666	-975 Reduced 2.34%	40,680 $5.64 Million
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $115,473 - $143,024	-1,080 Reduced 2.53%	41,655 $5.47 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $1.1 Million - $1.2 Million	-10,296 Reduced 19.42%	42,735 $4.78 Million
Q2 2019 Jul 12, 2019	SELL	$110.79 - $129.32 $105,139 - $122,724	-949 Reduced 1.76%	53,031 $0
Q1 2019 Apr 26, 2019	BUY	$111.31 - $131.02 $109,417 - $128,792	983 Added 1.85%	53,980 $0
Q4 2018 Jan 08, 2019	SELL	$105.9 - $118.64 $11,225 - $12,575	-106 Reduced 0.2%	52,997 $6.13 Million
Q3 2018 Oct 04, 2018	BUY	$85.86 - $107.31 $76,071 - $95,076	886 Added 1.7%	53,103 $0
Q2 2018 Jul 09, 2018	BUY	$75.7 - $86.88 $40,423 - $46,393	534 Added 1.03%	52,217 $0
Q1 2018 Apr 04, 2018	SELL	$74.21 - $87.6 $596,945 - $704,654	-8,044 Reduced 13.47%	51,683 $0
Q4 2017 Jan 23, 2018	SELL	$81.94 - $87.89 $129,874 - $139,305	-1,585 Reduced 2.59%	59,727 $0
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $4.73 Million - $5.24 Million	61,312	61,312 $0

Others Institutions Holding LLY

# of Institutions

4,395

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account